Pinderfields Hospital recruits first UK patient in 'landmark' cardiology trial
Pinderfields Hospital has become the first site in the UK to recruit a patient into a ‘landmark’ Phase III cardiology clinical trial.
The patient, who is from Wakefield, is currently undergoing aspects of the trial, which explores cardiovascular research delivery, at Pinderfields Hospital.
It marks a significant milestone for The Mid Yorkshire Teaching NHS Trust, and the teaching hospital, as well as the wider UK clinical research landscape.
Phase III trials represent a crucial stage in the development of new treatments, determining whether therapies are safe and effective for wider use.
Being selected to recruit the first UK patient into a global trial reflects international confidence in the NHS research system and the expertise of the frontline teams within the Wakefield hospital.
The milestone follows months of intensive preparation involving clinicians, research nurses, pharmacy teams, trial coordinators, governance specialists and operational staff.
Early access to cutting-edge treatments through clinical trials within the region offers new hope – particularly for those living with complex cardiovascular conditions across the district.
Principal Investigator for the trial Dr Ahmed Sabra, said: “Recruiting the first UK patient into this important Phase III trial is a fantastic achievement for everyone involved.
"It reflects the commitment, expertise and teamwork across our Trust.
"Most importantly, it ensures our patients have early access to potentially life-changing treatments while contributing to research that could benefit thousands more in the future.”
A spokesperson for The Mid Yorkshire Teaching NHS Trust said: “This latest milestone reinforces the Trust’s commitment to delivering outstanding research that benefits patients today while supporting the future of healthcare.”